Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Substitution of Antiepileptic Drugs
NCT02429596Phase 4Unknown
- Sponsor
- IRCCS Mondino Foundation
- Start
- May 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carbamazepine, valproic acid, topiramate, oxcarbazepine, levetiracetam in epilepsy, sponsored by IRCCS Mondino Foundation. Status: unknown.
02
Drugs
carbamazepinevalproic acidtopiramateoxcarbazepinelevetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02429596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429596.